AMPK Pathway Activation Improves the Sensitivity of Triple-Negative Breast Cancer Cells to Adriamycin
Tengteng Chen, Di Chen
AMPK Pathway Activation Improves the Sensitivity of Triple-Negative Breast Cancer Cells to Adriamycin
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |